Narrative review / 2013
Anthocyanins may reduce hepatic lipid accumulation and counteract oxidative stress and inflammation in nonalcoholic fatty liver disease.
This review summarizes evidence evaluating the mechanisms of action of anthocyanins on hepatic lipid metabolism across in vitro, in vivo, and human trials. Anthocyanins are reported to decrease hepatic lipid accumulation and may counteract oxidative stress and hepatic inflammation, though their impact on NAFLD remains to be fully determined. Based on the literature, the authors propose a working model outlining the mechanisms behind these potential benefits.
- Study type
- Narrative review
- Who was studied
- In vitro, in vivo, and human trial evidence on anthocyanins
- What was measured
- Hepatic lipid accumulation, oxidative stress, inflammation, and NAFLD mechanisms
THE PAPER
Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease.
Valenti L, Riso P, Mazzocchi A, Porrini M, Fargion S, Agostoni C. Oxid Med Cell Longev, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.